NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000028094

Registered date:06/07/2017

"Juzentaihoto" for fatigue of patients with solid cancer Observational study of feasibility and safety

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedFatigue in solid cancer patients
Date of first enrollment2016/10/19
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)juzentaihoto

Outcome(s)

Primary OutcomeFeasibility of juzentaihoto of cancer patients
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1)Those who have taken Kampo formula within the last 2 weeks 2)Women who are pregnant or breast feeding 3)Person who has history of hypersensitivity to juzentaihoto 4)In case the research practitioner determines that it is inappropriate

Related Information

Contact

public contact
Name Keiko Ogawa
Address 13-1 Takaramachi, Kanazawa-city, Ishikawa 920-8641 Japan 920-8641
Telephone 076-265-2918
E-mail okeiko@med.kanazawa-u.ac.jp
Affiliation Kanazawa University Hospital Department of Japanese-Traditional (Kampo) Medicine
scientific contact
Name Keiko Ogawa
Address 13-1 Takaramachi, Kanazawa-city, Ishikawa 920-8641 Japan
Telephone 076-265-2918
E-mail okeiko@med.kanazawa-u.ac.jp
Affiliation Kanazawa University Hospital Department of Japanese-Traditional (Kampo) Medicine